DARU Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish. 对乙酰氨基酚、甲咪唑和尼美舒利鸡尾酒对斑马鱼早期发育的毒理影响
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-07-11 DOI: 10.1007/s40199-024-00528-9
Wellington Fernandes de Carvalho, Ednalva de Souza Pereira Lima, Whocely Victor de Castro, Ralph Gruppi Thomé, Hélio Batista Santos
{"title":"Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish.","authors":"Wellington Fernandes de Carvalho, Ednalva de Souza Pereira Lima, Whocely Victor de Castro, Ralph Gruppi Thomé, Hélio Batista Santos","doi":"10.1007/s40199-024-00528-9","DOIUrl":"10.1007/s40199-024-00528-9","url":null,"abstract":"<p><strong>Background: </strong>Several countries' most incorrectly discarded medicines are acetaminophen (ACM), metamizole (MTZ), and nimesulide (NMS). These xenobiotics easily reach the aquatic environment; such contamination is very important for the health of humans and other species, yet little explored.</p><p><strong>Objectives: </strong>To evaluate the cocktail effect of ACM, MTZ, and NMS during zebrafish's initial development.</p><p><strong>Methods: </strong>Zebrafish embryos 6-8 h post-fertilization (hpf) were exposed to different concentrations of ACM, MTZ, and NMS, separately, to obtain the 50% lethal concentrations (LC<sub>50</sub>). Next, the embryos were exposed to distinct concentrations of the cocktail (LC<sub>50</sub>/2, LC<sub>50</sub>/5, LC<sub>50</sub>/10, and LC<sub>50</sub>/20) in a semi-static system. Samples were analyzed 0, 24, 48, and 96 h after exposure, and the drugs' concentrations in E3 medium were assessed by high-performance liquid chromatography. For embryotoxicity evaluation, the mortality, hatching, and heart rates; total length; and pericardial and yolk sac areas were determined. In addition, body malformations, edemas, presence of pigmentation, and histopathological assessments were also recorded.</p><p><strong>Results: </strong>The LC<sub>50</sub> values obtained for MTZ, ACM, and NMS were 4.69 mgmL<sup>-1</sup>, 799.98 μgmL<sup>-1</sup>, and 0.92 μgmL<sup>-1</sup>, respectively. No difference was observed between the drugs' nominal and observed concentrations at each time point. The cocktail significantly induced mortality and decreased hatching in the LC<sub>50</sub>/10, LC<sub>50</sub>/5, and LC<sub>50</sub>/2 groups. Additionally, body malformations, pigmentation loss, and yolk sac and pericardial edemas were observed in the cocktail groups. The cocktail groups' larvae had decreased total length and slower heart rates compared to the controls (p < 0.05). The histopathological assessment showed that yolk sac edema promoted severe histological changes in the esophageal-intestine junction and intestine in larvae treated with cocktails. Moreover, PAS-positive structures decreased in the esophageal-intestine junction, intestine, and liver in larvae exposed to pharmaceutical cocktails.</p><p><strong>Conclusion: </strong>This study's findings suggest the cocktail of ACM, MTZ, and NMS may be hazardous to aquatic organisms in case of environmental contamination.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"585-597"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication. COVID-19 疗法的抗药性和副作用的合理机制:根除该疾病的瓶颈。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-07-19 DOI: 10.1007/s40199-024-00524-z
Swarnali Das, Sreyashi Nath, Shahjahan, Sanjay Kumar Dey
{"title":"Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication.","authors":"Swarnali Das, Sreyashi Nath, Shahjahan, Sanjay Kumar Dey","doi":"10.1007/s40199-024-00524-z","DOIUrl":"10.1007/s40199-024-00524-z","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 pandemic has turned our world upside down by meddling with our normal lives. While there is no definitive drug against SARS-CoV-2, antiviral drugs that are already in the market, are being repurposed against it, could now complete long-term as well as all age-specific investigations, and they are successful in saving millions of lives. Nevertheless, side-effects are emergingly seen in the patients undergoing treatment, and ineffectiveness is increasingly found due to the emerging notorious variants of the virus. Many of them are also facing serious co-infections including black fungus, Zika, and H1N1 virus to name a few.</p><p><strong>Objectives: </strong>Therefore, this review highlights both drug resistance, their side-effects, and the significance for proper and long-term clinical trials of all age groups including children.</p><p><strong>Methods: </strong>We have explored and proposed the mechanisms of drug resistance that may arise due to the misuse or overuse of drugs based on available experimental reports.</p><p><strong>Results: </strong>The review provides solutions to the aforesaid issues of drug-resistance and side-effects by providing combination therapies, ancillary treatments, and other preventive strategies that can be useful in preventing drawbacks thereby curbing COVID-19 or similar future infections to maintain our normal lives.</p><p><strong>Conclusion: </strong>COVID-19 and its long-term effects, if any, can be eradicated with strategic and mindful use of related therapeutics in a controlled manner.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"801-823"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men. 健康韩国男性体内洛索洛芬及其酒精代谢物的群体药代动力学。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-08-15 DOI: 10.1007/s40199-024-00533-y
Ji-Hun Jang, Ho-Suk Kang, Seung-Hyun Jeong
{"title":"Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men.","authors":"Ji-Hun Jang, Ho-Suk Kang, Seung-Hyun Jeong","doi":"10.1007/s40199-024-00533-y","DOIUrl":"10.1007/s40199-024-00533-y","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Loxoprofen has been actively used clinically to relieve musculoskeletal pain and inflammatory symptoms. However, there are few reports on quantitative pharmacokinetic (PK) prediction tools and diversity analyzes for loxoprofen within populations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The aim of this study was to identify effective covariates associated with explaining inter-individual PK variability through a population pharmacokinetic (Pop-PK) modeling approach for loxoprofen, and to provide a starting point for establishing scientific dosing regimens.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;The bioequivalence PK results of loxoprofen performed on 52 healthy Korean men and the physiological and biochemical parameters derived from each individual were used as base data for the development of a Pop-PK model of loxoprofen. In order to simultaneously predict the PKs of the active form according to loxoprofen exposure, previously reported PK results of trans-alcohol loxoprofen, an active metabolite of loxoprofen, were used to expand the model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The Pop-PK profiles of loxoprofen were described in terms of the basic structure of a non-sequential two absorption with 2-disposition compartment, and for inter-individual PK variations, peripheral compartment volume of distribution could be correlated with body surface area (BSA), and central compartment clearance with creatinine clearance (CrCL) and albumin levels. As a result of the model simulation, the concentrations of loxoprofen and its alcoholic metabolites in plasma significantly decreased as CrCL and albumin levels increased and decreased, respectively. On the other hand, it was confirmed that the higher the BSA, the greater the distribution of loxoprofen to the periphery, and the minimum concentrations of loxoprofen and alcoholic metabolites in plasma in steady-state increased by approximately 1.78-2 times, while the fluctuation between maximum and minimum concentrations decreased. The results suggest that patients with large BSA, impaired renal function, and high serum albumin levels may have significantly higher plasma exposure to loxoprofen and trans-alcohol loxoprofen. It was also suggested that the potential side effects in the gastrointestinal system and various tissues and the level of exposure in plasma due to long-term application of loxoprofen in this patient group could be causally explained.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study provides a very useful starting point for a scientific precision medicine approach to loxoprofen by discovering effective covariates and establishing a quantitative model that can explain the diversity of loxoprofen PKs within the population.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical trial registration: &lt;/strong&gt;The clinical study protocol used in this study was thoroughly reviewed and approved by the Institutional Review Board of the Institute of Bioequivalence and Bridging Study, Chonnam National University, Gwangju, Rep","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"631-648"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public interest in drug-related problems reflected in information search trends: an infodemiological study. 信息搜索趋势所反映的公众对毒品相关问题的兴趣:一项信息空间学研究。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-06-18 DOI: 10.1007/s40199-024-00519-w
Laura Martínez-Aguilar, María Sanz-Lorente, Fernando Martínez-Martínez, María J Faus, Javier Sanz-Valero
{"title":"Public interest in drug-related problems reflected in information search trends: an infodemiological study.","authors":"Laura Martínez-Aguilar, María Sanz-Lorente, Fernando Martínez-Martínez, María J Faus, Javier Sanz-Valero","doi":"10.1007/s40199-024-00519-w","DOIUrl":"10.1007/s40199-024-00519-w","url":null,"abstract":"<p><strong>Background: </strong>The analysis of how people search and \"navigate\" the internet to obtain health-related information and how they communicate and share this information can provide valuable knowledge about the disease patterns behaviour and health habits of populations.</p><p><strong>Objective: </strong>To determine the population's interest in drug-related problems through information search trends.</p><p><strong>Method: </strong>A descriptive ecological correlational study, based on obtaining Google Trends data.</p><p><strong>Variables studied: </strong>relative search volume (RSV), evolution over time, milestones and seasonality.</p><p><strong>Results: </strong>The most searched topic was drug overdose, with mean RSV of 56.25 ± 0.65. The highest increase occurred in the contraindication topic (R<sup>2</sup> = 0.87, p < 0.001). The main milestone was observed in the drug overdose topic in July 2018 (RSV = 100). A very close relationship was found between adverse drug reaction and contraindication (R = 0.89, p < 0.001). Slight seasonality was noted in the adverse drug reaction (augmented Dickey-Fuller test [ADF] = -1.96), contraindication (ADF = -2.66) and drug interaction (ADF = -1.67) topics, but did not show an epidemiological trend.</p><p><strong>Conclusions: </strong>The greatest public interest was found in the drug overdose and contraindication topics, which showed a stronger upward trend, although the seasonality study did not show any very notable data or demonstrate epidemiological information search behaviour. The main milestone observed was due to media factors related to the consumption of narcotics. There was a clear difference in English-speaking countries in the use of the drug overdose topic. A correlation between the adverse drug reaction and contraindication topics was confirmed.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"537-547"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141418206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study. 含有富马酸二甲酯和苯并噻唑支架的混合衍生物用于多发性硬化症的潜在治疗;硅学和体内研究。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-08-06 DOI: 10.1007/s40199-024-00529-8
Seyedeh Azin Mirmotahari, Mehdi Aliomrani, Farshid Hassanzadeh, Hajar Sirous, Mahboubeh Rostami
{"title":"Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study.","authors":"Seyedeh Azin Mirmotahari, Mehdi Aliomrani, Farshid Hassanzadeh, Hajar Sirous, Mahboubeh Rostami","doi":"10.1007/s40199-024-00529-8","DOIUrl":"10.1007/s40199-024-00529-8","url":null,"abstract":"<p><strong>Background: </strong>Multiple Sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the CNS. Riluzole and dimethyl fumarate (DMF) are two FDA-approved drugs to treat amyotrophic lateral sclerosis (ALS) and MS. Riluzole (a benzothiazole derivative) inhibits glutamate release from nerve terminals by antagonizing the N-Methyl-D-Aspartate (NMDA) receptor, and DMF upregulates anti-oxidative pathways.</p><p><strong>Objectives: </strong>Herein, using molecular hybridization strategy, we synthesized some new hybrid structures of Riluzole and DMF through some common successive synthetic pathways for evaluating their potential activity for remyelination in MS treatment.</p><p><strong>Methods: </strong>Molecular docking experiments assessed the binding affinity of proposed structures to the NMDA active site. The designed structures were synthesized and purified based on well-known chemical synthesis procedures. Afterward, in vivo evaluation for their activity was done in the C57Bl/6 Cuprizone-induced demyelination MS model.</p><p><strong>Results and conclusion: </strong>The proposed derivatives were recognized to be potent enough based on docking studies (ΔG<sub>bind</sub> of all derivatives were -7.2 to -7.52 compare to the Ifenprodil (-6.98) and Riluzole (-4.42)). The correct structures of desired derivatives were confirmed using spectroscopic methods. Based on in vivo studies, D4 and D6 derivatives exhibited the best pharmacological results, although only D6 showed a statistically significant difference compared to the control. Also, for D4 and D6 derivatives, myelin staining confirmed reduced degeneration in the corpus callosum. Consequently, D4 and D6 derivatives are promising candidates for developing new NMDA antagonists with therapeutic value against MS disorders.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"599-615"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies. 干粉吸入器设计与颗粒技术在提高肺部药物沉积方面的应用:挑战与未来战略。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-06-11 DOI: 10.1007/s40199-024-00520-3
Nazrul Islam, Tan Suwandecha, Teerapol Srichana
{"title":"Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.","authors":"Nazrul Islam, Tan Suwandecha, Teerapol Srichana","doi":"10.1007/s40199-024-00520-3","DOIUrl":"10.1007/s40199-024-00520-3","url":null,"abstract":"<p><strong>Objectives: </strong>The efficient delivery of drugs from dry powder inhaler (DPI) formulations is associated with the complex interaction between the device design, drug formulations, and patient's inspiratory forces. Several challenges such as limited emitted dose of drugs from the formulation, low and variable deposition of drugs into the deep lungs, are to be resolved for obtaining the efficiency in drug delivery from DPI formulations. The objective of this study is to review the current challenges of inhaled drug delivery technology and find a way to enhance the efficiency of drug delivery from DPIs.</p><p><strong>Methods/evidence acquisition: </strong>Using appropriate keywords and phrases as search terms, evidence was collected from the published articles following SciFinder, Web of Science, PubMed and Google Scholar databases.</p><p><strong>Results: </strong>Successful lung drug delivery from DPIs is very challenging due to the complex anatomy of the lungs and requires an integrated strategy for particle technology, formulation design, device design, and patient inhalation force. New DPIs are still being developed with limited performance and future device design employs computer simulation and engineering technology to overcome the ongoing challenges. Many issues of drug formulation challenges and particle technology are concerning factors associated with drug dispersion from the DPIs into deep lungs.</p><p><strong>Conclusion: </strong>This review article addressed the appropriate design of DPI devices and drug formulations aligned with the patient's inhalation maneuver for efficient delivery of drugs from DPI formulations.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"761-779"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the relationship between inflammation and microbiota in the intestinal tissue of female and male rats fed with fructose: Modulatory role of metformin. 研究果糖喂养的雌性和雄性大鼠肠道组织中炎症与微生物群之间的关系:二甲双胍的调节作用
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-06-17 DOI: 10.1007/s40199-024-00521-2
Azimet Yalçın Buğdaycı, Saadet Özen Akarca Dizakar, Mürşide Ayşe Demirel, Suna Ömeroğlu, Fatma Akar, Mecit Orhan Uludağ
{"title":"Investigation of the relationship between inflammation and microbiota in the intestinal tissue of female and male rats fed with fructose: Modulatory role of metformin.","authors":"Azimet Yalçın Buğdaycı, Saadet Özen Akarca Dizakar, Mürşide Ayşe Demirel, Suna Ömeroğlu, Fatma Akar, Mecit Orhan Uludağ","doi":"10.1007/s40199-024-00521-2","DOIUrl":"10.1007/s40199-024-00521-2","url":null,"abstract":"<p><strong>Background: </strong>It has been reported that High-Fructose (HF) consumption, considered one of the etiological factors of Metabolic Syndrome (MetS), causes changes in the gut microbiota and metabolic disorders. There is limited knowledge on the effects of metformin in HF-induced intestinal irregularities in male and female rats with MetS.</p><p><strong>Objectives: </strong>In this study, we investigated the sex-dependent effects of metformin treatment on the gut microbiota, intestinal Tight Junction (TJ) proteins, and inflammation parameters in HF-induced MetS.</p><p><strong>Methods: </strong>Fructose was given to the male and female rats as a 20% solution in drinking water for 15 weeks. Metformin (200 mg/kg) was administered by gastric tube once a day during the final seven weeks. Biochemical, histopathological, immunohistochemical, and bioinformatics analyses were performed. Differences were considered statistically significant at p < 0.05.</p><p><strong>Results: </strong>The metformin treatment in fructose-fed rats promoted glucose, insulin, Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR), and Triglyceride (TG) values in both sexes. The inflammation score was significantly decreased with metformin treatment in fructose-fed male and female rats (p < 0.05). Moreover, metformin treatment significantly decreased Interleukin-1 Beta (IL-1β) and Tumor Necrosis Factor-Alpha (TNF-α) in ileum tissue from fructose-fed males (p < 0.05). Intestinal immunoreactivity of Occludin and Claudin-1 was increased with metformin treatment in fructose-fed female rats. HF and metformin treatment changed the gut microbial composition. Firmicutes/Bacteroidetes (F/B) ratio increased with HF in females. In the disease group, Bifidobacterium pseudolongum; in the treatment group, Lactobacillus helveticus and Lactobacillus reuteri are the prominent species in both sexes. When the male and female groups were compared, Akkermansia muciniphila was prominent in the male treatment group.</p><p><strong>Conclusion: </strong>In conclusion, metformin treatment promoted biochemical parameters in both sexes of fructose-fed rats. Metformin showed a sex-dependent effect on inflammation parameters, permeability factors, and gut microbiota. Metformin has partly modulatory effects on fructose-induced intestinal changes.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"515-535"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid management strategies for diabetic patients align with an evidence-based guideline. 糖尿病患者的血脂管理策略符合循证指南。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-09-06 DOI: 10.1007/s40199-024-00534-x
Mona Kargar, Noushid Zare, Aarefeh Jafarzadeh Kohneloo, Fatemeh Afra, Elham Hadidi, Kheirollah Gholami
{"title":"Lipid management strategies for diabetic patients align with an evidence-based guideline.","authors":"Mona Kargar, Noushid Zare, Aarefeh Jafarzadeh Kohneloo, Fatemeh Afra, Elham Hadidi, Kheirollah Gholami","doi":"10.1007/s40199-024-00534-x","DOIUrl":"10.1007/s40199-024-00534-x","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) increases the risk of cardiovascular diseases (CVD) significantly. Statins are recommended for all diabetic patients aged ≥ 40 years to alleviate this risk.</p><p><strong>Objectives: </strong>This study aimed to determine the status of the implementation of the recommendations of lipid management strategies for diabetic patients.</p><p><strong>Methods: </strong>In this cross-sectional study, 500 patients with DM, aged ≥ 40 referring to a public pharmacy with at least one diabetic medication in their prescription, were enrolled. Patients' demographics, lipid panel data, medications, personal and family history of atherosclerotic cardiovascular disease (ASCVD), and risk factors for ASCVD were documented. The appropriateness of stain dosing intensity was judged based on the American Diabetes Association (ADA) guideline.</p><p><strong>Results: </strong>The mean ± SD of the age of patients was 61.39 ± 10.49 years. Among patients, 238 (47.6) were men. More than half of the patients were subject to receiving primary prevention (59.8%, n = 299). For 80.8% (n = 404) of patients, a statin, most frequently atorvastatin (61.8%), was prescribed. The appropriate statin dose based on the guideline for 470 patients (94%), was high-intensity statin. In 70.6% (n = 353) of patients, lipid management was not in accordance with the guideline. Patients with ASCVD were more likely to receive the statins and the appropriate doses compared to patients without ASCVD (p-value < 0.001).</p><p><strong>Conclusion: </strong>Despite a relatively high percentage of patients who received statins, the lipid management in most patients was not in accordance with the guideline. The profound problem was the suboptimal dosage of statins. Investigating the reasons and barriers of the appropriate management can be helpful. Additionally, since patients without ASCVD who should receive statins for primary prevention were significantly less likely to receive statins and evidence-based doses, more attention is needed for this population.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"665-673"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence). 基于机器学习技术(人工智能)预测阿片类药物中毒时的纳洛酮剂量。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-05-21 DOI: 10.1007/s40199-024-00518-x
Seyed Ali Mohtarami, Babak Mostafazadeh, Shahin Shadnia, Mitra Rahimi, Peyman Erfan Talab Evini, Maral Ramezani, Hamed Borhany, Mobin Fathy, Hamidreza Eskandari
{"title":"Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence).","authors":"Seyed Ali Mohtarami, Babak Mostafazadeh, Shahin Shadnia, Mitra Rahimi, Peyman Erfan Talab Evini, Maral Ramezani, Hamed Borhany, Mobin Fathy, Hamidreza Eskandari","doi":"10.1007/s40199-024-00518-x","DOIUrl":"10.1007/s40199-024-00518-x","url":null,"abstract":"<p><strong>Background: </strong>Treatment management for opioid poisoning is critical and, at the same time, requires specialized knowledge and skills. This study was designed to develop and evaluate machine learning algorithms for predicting the maintenance dose and duration of hospital stay in opioid poisoning, in order to facilitate appropriate clinical decision-making.</p><p><strong>Method and results: </strong>This study used artificial intelligence technology to predict the maintenance dose and duration of administration by selecting clinical and paraclinical features that were selected by Pearson correlation (filter method) (Stage 1) and then the (wrapper method) Recursive Feature Elimination Cross-Validated (RFECV) (Stage2). The duration of administration was divided into two categories: A (which includes a duration of less than or equal to 24 h of infusion) and B (more than 24 h of naloxone infusion). XGBoost algorithm model with an accuracy rate of 91.04%, a prediction rate of 91.34%, and a sensitivity rate of 91.04% and area under the Curve (AUC) 0.97 was best model for classification patients. Also, the best maintenance dose of naloxone was obtained with XGBoost algorithm with R<sup>2</sup> = 0.678. Based on the selected algorithm, the most important features for classifying patients for the duration of treatment were bicarbonate, respiration rate, physical sign, The partial pressure of carbon dioxide (PCO<sub>2</sub>), diastolic blood pressure, pulse rate, naloxone bolus dose, Blood Creatinine(Cr), Body temperature (T). The most important characteristics for determining the maintenance dose of naloxone were physical signs, bolus dose of 4.5 mg/kg, Glasgow Coma Scale (GCS), Creatine Phosphokinase (CPK) and intensive care unit (ICU) add.</p><p><strong>Conclusion: </strong>A predictive model can significantly enhance the decision-making and clinical care provided by emergency physicians in hospitals and medical settings. XGBoost was found to be the superior model.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"495-513"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-pot synthesis of polysaccharide/gelatin amorphous hydrogels impregnated with a bioflavonoid derived from Elaeis guineensis leaf: wound healing and drug release properties. 多糖/明胶无定形水凝胶的一锅合成:伤口愈合和药物释放特性。
IF 2.5 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2024-12-01 Epub Date: 2024-09-28 DOI: 10.1007/s40199-024-00540-z
Mohamad Shazeli Che Zain, Mohammed Danish, Khozirah Shaari, Sharida Fakurazi
{"title":"One-pot synthesis of polysaccharide/gelatin amorphous hydrogels impregnated with a bioflavonoid derived from Elaeis guineensis leaf: wound healing and drug release properties.","authors":"Mohamad Shazeli Che Zain, Mohammed Danish, Khozirah Shaari, Sharida Fakurazi","doi":"10.1007/s40199-024-00540-z","DOIUrl":"10.1007/s40199-024-00540-z","url":null,"abstract":"<p><strong>Background: </strong>Amorphous hydrogel is a strategic wound healing dressings that comprised of water, polymers and excipients with no shape. The dense cross-linked network of polymer is interspersed by the immobilized water component could rehydrate and promote healing in wound tissue.</p><p><strong>Objective: </strong>In this work, various polysaccharide/gelatin amorphous hydrogels with the impregnation of oil palm leaf derived total flavonoid enriched extract (OPL-TFEE) were fabricated via one-pot synthesis method to provide multiple crosslinking networks.</p><p><strong>Method: </strong>The bioflavonoids (OPL-TFEE) were derived from Elaeis guineensis leaf using an integrated green extraction and enrichment process. Amorphous hydrogels with good wound healing properties were developed by incorporating 0.3% antioxidant agent into the hybrid polymeric gelling system.</p><p><strong>Result: </strong>The formulations appeared as a semi-solid dark yellow translucent hydrogel with good spreading and consistency characteristics and satisfying aesthetic properties. The FTIR analysis indicated that the bioflavonoid was compatible with the matrix, and the hydrogels showed porous morphological structures when observed under SEM. Furthermore, the hydrogels possessed shear thinning, pseudoplastic, and elastic properties. Bioflavonoids-impregnated polysaccharide/gelatin hydrogel release 95-98% bioflavonoids within 24 h, while the drug release profile followed the Korsmeyer-Peppas kinetic model. The hydrogels showed antioxidant and wound healing properties with no sign of cytotoxicity.</p><p><strong>Conclusion: </strong>Overall, the results revealed bioflavonoid-loaded hydrogels exhibited good physicochemical and biological properties, thus could serve as new innovative formulation in the sustainable advancement of wound care product for promoting wound healing.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":" ","pages":"689-703"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142343310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信